Expiration date: 04/2025

Composition

active substance:

Mirolut ® or Misoprostol-GPMC (contains misoprostol -200 mcg in terms of 100% substance, hypromellose) - 20 mg

excipients: Prosolv (MCC and silicon dioxide colloidal) - 166 mg; sodium carboxymethyl starch-12 mg; magnesium stearate-2 mg

Pharmacological action

Pharmacological action-stimulating labor activity, prostaglandin-like.

Dosage and administration

Inside.

36-48 hours after taking 600 mg (3 tables) of mifepristone, 400 micrograms (2 tables) of Mirolut ® are prescribed.

Form release

Tablets, 200 mcg. By 4 or 10 tables. in a contour cell package made of PVC film/PVDC and aluminum foil printed patent. 4, 10, 20 or 30 tables in a polymer jar. A package is placed in the jar or a container with silica gel is fixed in the lid of the jar. 1 Bank or 1, 2, 3, 4 or 10 contour cell packages in a pack of cardboard.

Manufacturer

Obninsk chemical and pharmaceutical company CJSC. 4 Koroleva str., Obninsk, Kaluga region, Russia, 249036.

Tel. / Fax: (48439) 6-47-41.

Address of the place of production: Kaluga region, Obninsk, Kievskoe sh., ZD. 103, ZD. 107.

Owner of the registration certificate/organization accepting claims: JSC "Nizhpharm", 603950, Russia, Nizhny Novgorod, ul.Salganskaya, 7.

Tel.: (831) 278-80-88; Fax: (831) 430-72-28.

e-mail: [email protected]

Conditions of release from pharmacies

Leave only to medical obstetric and gynecological institutions that belong to the state health system, as well as to institutions of municipal and private ownership that have licenses for this type of activity.

Storage conditions of the drug Microlut ®

In a dry, protected from light place, at a temperature no higher than 25 °C.

Keep out of the reach of children.